CHARINA CRUZ YANGO CADAVOS

Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine NAPLES, FL NPI 1497790844

General Payments — all program years on this page

$2,426.26

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $385.20 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $1,183.888
2020 $54.733
2021 $335.2212
2022 $244.555
2023 $222.687
2024 $385.2016

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087424044 Novartis Pharmaceuticals Corporation $17.86 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424046 Novartis Pharmaceuticals Corporation $17.82 04/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424048 Novartis Pharmaceuticals Corporation $33.31 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424050 Novartis Pharmaceuticals Corporation $17.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424052 Novartis Pharmaceuticals Corporation $15.22 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424054 Novartis Pharmaceuticals Corporation $21.65 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424056 Novartis Pharmaceuticals Corporation $15.71 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087424058 Novartis Pharmaceuticals Corporation $17.48 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097015932 Novo Nordisk Inc $23.15 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097281772 Novo Nordisk Inc $20.77 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106371574 ABBVIE INC. $81.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1114955366 Exact Sciences Corporation $24.86 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116419539 GlaxoSmithKline, LLC. $20.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119007391 Otsuka America Pharmaceutical, Inc. $25.82 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136100722 Lilly USA, LLC $16.57 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136111774 Lilly USA, LLC $15.58 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.